GeneDx plans to acquire Fabric Genomics, an AI-powered genomic interpretation company, for $33M.
The acquisition aims to position GeneDx in the forefront of decentralized genomic medicine with centralized intelligence.
GeneDx and Fabric Genomics believe that this partnership will lead to faster diagnoses, improved patient outcomes, and reduced costs for healthcare systems.
The acquisition will enable GeneDx to expand its market reach in areas such as NICU genomic testing, genomic newborn screening, and global commercial expansion.